Chapter title |
Molecular Biology of Glioma.
|
---|---|
Chapter number | 1 |
Book title |
Glioma
|
Published in |
Advances in experimental medicine and biology, January 2012
|
DOI | 10.1007/978-1-4614-3146-6_1 |
Pubmed ID | |
Book ISBNs |
978-1-4614-3145-9, 978-1-4614-3146-6
|
Authors |
Marumoto, Tomotoshi, Saya, Hideyuki, Tomotoshi Marumoto, Hideyuki Saya |
Abstract |
Glioblastoma (GBM) is the most aggressive form of glioma. Despite ceaseless efforts by researchers and physicians to find new therapeutic strategies, there have been no significant advances in the treatment of GBMs for several decades and most patients with GBM die within one and half years of diagnosis. Undoubtedly, one reason for this is the insufficient understanding of the initiation and progression of GBMs at the molecular level. However, recent information regarding the genetic and epigenetic alterations and the microRNAs that are aberrantly activated or inactivated in GBMs has helped elucidate the formation of GBM in more detail. Here, we describe recent advances in the understanding of the biology of GBMs. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 2% |
United States | 1 | 2% |
Egypt | 1 | 2% |
Unknown | 56 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 14 | 24% |
Student > Master | 9 | 15% |
Researcher | 7 | 12% |
Student > Bachelor | 6 | 10% |
Student > Doctoral Student | 5 | 8% |
Other | 11 | 19% |
Unknown | 7 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 22 | 37% |
Medicine and Dentistry | 12 | 20% |
Biochemistry, Genetics and Molecular Biology | 8 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Chemistry | 2 | 3% |
Other | 4 | 7% |
Unknown | 9 | 15% |